Biosimilars and Bone Health - Episode 1

Optimizing Biosimilar Treatment Strategies in Bone Health

Colin C. Edgerton, MD, discusses key considerations for utilizing biosimilars in the bone health treatment landscape.

Now Viewing
EP. 1: Optimizing Biosimilar Treatment Strategies in Bone Health
EP. 2: Managing Treatment Strategies for Osteoporosis Amid Evolving Biologic and Biosimilar Landscape

*Content was developed independently by The Center for Biosimilars® and supported by Sandoz.

Related Content:

Video SeriesInterviewsInsightsClinical
The Top 5 Biosimilar Articles for the Week of November 18
Can Global Policies to Boost Biosimilar Adoption Work in the US?
How Strategic IDNs Boost Biosimilar Adoption